Taro, Sandoz fail to get quick appeal in states' US case over generic drug prices
MLex Summary: Taro Pharmaceuticals and Sandoz were denied leave to immediately appeal a judgment on liability in an antitrust case accusing them of conspiring over generic drug pricing. District Judge Michael P....To view the full article, register now.
Already a subscriber? Click here to view full article